Lushang Freda PharmaceuticalLtd 配当金
配当金 基準チェック /26
Lushang Freda PharmaceuticalLtd is a dividend paying company with a current yield of 1.47% that is well covered by earnings.
主要情報
1.5%
配当利回り
-0.3%
バイバック利回り
| 総株主利回り | 1.2% |
| 将来の配当利回り | 2.3% |
| 配当成長 | 5.5% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | CN¥0.100 |
| 配当性向 | 63% |
最近の配当金アップデート
更新なし
Recent updates
Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Doing What It Can To Lift Shares
Jun 21
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27決済の安定と成長
配当データの取得
安定した配当: 600223 has been paying a dividend for less than 10 years and during this time payments have been volatile.
増加する配当: 600223's dividend payments have increased, but the company has only paid a dividend for 5 years.
配当利回り対市場
| Lushang Freda PharmaceuticalLtd 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (600223) | 1.5% |
| 市場下位25% (CN) | 0.6% |
| 市場トップ25% (CN) | 2.2% |
| 業界平均 (Real Estate) | 2.3% |
| アナリスト予想 (600223) (最長3年) | 2.3% |
注目すべき配当: 600223's dividend (1.47%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
高配当: 600223's dividend (1.47%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
株主への利益配当
収益カバレッジ: With its reasonable payout ratio (62.8%), 600223's dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: With its high cash payout ratio (179.7%), 600223's dividend payments are not well covered by cash flows.